Michael Lobritz

Michael Lobritz, MD, PhD is Global Head of the Infectious Diseases Therapeutic Area at Roche Pharma Research & Early Development, where he and the Roche team focus on discovery and translational development of novel antibiotics and antivirals to address threats to Global Health Security. He additionally serves on the Board of Directors of the AMR Industry Alliance and AMR Action Fund. Prior to joining Roche, Michael was attending physician in medicine and infectious diseases at Massachusetts General Hospital and Harvard Medical School in Boston, USA. He is a Fellow of the Infectious Diseases Society of America